Clinical Trials on Rhinoconjunctivitis, Allergic

Total 2487 results

Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis

Switzerland
Allergy Therapeutics
Ecarf Institute GmbH; Bencard Allergie GmbH

Completed

Effect of holoBLG on Cat Allergic Patients

Allergic Rhinoconjunctivitis | Allergy to Cats

Germany
Inmunotek S.L.
BioClever 2005 S.L.; NTS hub S.L

Terminated

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Perennial Allergic Rhinitis | Allergic Rhinoconjunctivitis | House Dust Mite Allergy | Pollen Allergy

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy

Allergic Rhinoconjunctivitis

Spain
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis

United States
Medical University of Graz

Recruiting

Nasal Mucus Proteome and Immunotherapy

Allergic Rhinoconjunctivitis

Austria
Immunomic Therapeutics, Inc.

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis

United States
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration (ZU-SkinSIT-003)

Allergic Rhinoconjunctivitis

Switzerland
West Penn Allegheny Health System
Greer Laboratories

Completed

Normal Values of Facial Thermography

Healthy | Allergy | Allergic Rhinoconjunctivitis

United States
ALK-Abelló A/S

Completed

A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine (GT-19)

Allergic Rhinoconjunctivitis

Germany
ClinNovis GmbH

Completed

Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis

Rhinoconjunctivitis, Allergic

Germany
ALK-Abelló A/S

Completed

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) (AIRS)

Allergic Rhinoconjunctivitis
Laboratorios Leti, S.L.

Completed

Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis (GPIT)

Allergic Rhinoconjunctivitis

South Africa
NTC srl

Completed

Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics

Allergic Rhinoconjunctivitis

Italy
Roxall Medicina España S.A

Completed

Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

Allergic Rhinoconjunctivitis

Spain
Allergopharma GmbH & Co. KG

Completed

Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Germany
Artu Biologicals

Completed

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
BioTech Tools S.A.

Completed

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Allergopharma GmbH & Co. KG
Inflamax Research Incorporated

Terminated

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

Healthy Volunteers | Allergic Rhinoconjunctivitis

Canada
University Hospital, Antwerp
DSM Nutritional Products, Inc.

Completed

Probiotic Chewables in Allergic Rhinoconjunctivitis Patients

Allergic Rhinoconjunctivitis

Belgium
Artu Biologicals

Completed

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
Artu Biologicals

Unknown

A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis

Allergic Rhinoconjunctivitis

Netherlands, United Kingdom, Germany, Poland, Belgium, France
Cytos Biotechnology AG

Completed

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Perennial Allergy to House Dust Mite and/or Cat

Estonia, Latvia, Lithuania
Cytos Biotechnology AG

Completed

Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

Rhinoconjunctivitis | Allergies

Estonia, Germany, Greece, Latvia, Lithuania, Romania
Inmunotek S.L.
LAT Research; Xolomon Tree S.L.

Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract (MM09-SLIM)

Allergic Rhinitis | Allergic Asthma | Allergic Rhinoconjunctivitis | Allergy to House Dust Mite

Argentina
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Allergopharma GmbH & Co. KG

Completed

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Allergic Rhinoconjunctivitis

Sweden
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy (AV-X-02)

Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen

Spain
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
BioTech Tools S.A.

Completed

Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

Allergic Rhinoconjunctivitis

Spain
Inmunotek S.L.
BioClever 2005 S.L.; NTS hub S.L

Not yet recruiting

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Perennial Allergic Rhinitis | Allergic Asthma | Allergic Rhinoconjunctivitis | House Dust Mite Allergy

Spain
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
Odense University Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); European... and other collaborators

Completed

S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen (BM41)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Denmark
Stallergenes Greer

Active, not recruiting

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma (YOBI)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Germany
National Polytechnic Institute, Mexico
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

Allergic Rhinoconjunctivitis
BioTech Tools S.A.

Completed

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Roxall Medicina España S.A

Completed

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain, Portugal
Leti Pharma GmbH
Pierrel Research Europe GmbH; Laboratorios LETI SL (Study Medication); Labor...

Completed

Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma | Immunotherapy, Allergen

Germany, Lithuania, Poland
University of Zurich
AlleCure

Completed

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Rhinoconjunctivitis Due to Grass Pollen Allergy

Switzerland
ORA, Inc.

Completed

A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube

Allergic Rhinoconjunctivitis

United States
Roxall Medicina España S.A

Completed

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S
Inflamax Research Incorporated

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Allergic Rhinoconjunctivitis

Canada
Charite University, Berlin, Germany

Completed

Vitamin D and Grass Pollen Specific Immunotherapy

Allergic Rhinoconjunctivitis

Germany
Menarini International Operations Luxembourg SA

Completed

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma (SKY)

Asthma | Seasonal Allergic Rhinoconjunctivitis

Poland, Romania, Germany, Italy, Czechia, Latvia, Croatia, Slovakia
Starx Research Center, LLC

Unknown

Ocular Allergy Treatment Practical Impact Trial ((OAT-PIT))

Allergic Conjunctivitis | Rhinoconjunctivitis

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

ToleroMune Grass Follow on Study

Grass Allergy | Rhinoconjunctivitis

Canada

Clinical Trials on Rhinoconjunctivitis, Allergic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations